24/7 Wall Street
04 Sept 2026, 14:45 UTC · 1h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Analysis by Kasper Rasmussen · Founder & analyst
What the story claims
5 claims · each scored for market impact
Intuitive Surgical (ISRG) has seen 25 upward Wall Street EPS revisions for FY2026 within a 30-day window. — Concentrated analyst upgrades typically precede positive price action and indicate strong institutional conviction.
+0.80Intuitive Surgical's recurring revenue now accounts for 85% of its total revenue, supported by an installed base of 11,710 da Vinci systems. — High recurring revenue reduces volatility and creates a compounding growth moat that is highly valued by long-term investors.
+0.60Stryker (SYK) reported 9% organic sales growth while recovering from a March cyber incident. — Positive organic growth despite operational headwinds suggests resilience, though it is less of a structural catalyst than ISRG's moat.
+0.40Continue reading
6 related stories
Top 3 movers · tap to explore
Stryker's Vascular segment declined 0.7% due to supply disruptions at an Inari plant, with resolution expected by the end of Q3. — Short-term supply chain headwinds create a drag on a specific segment, though the timeline for recovery is defined.
-0.30Both Intuitive Surgical and Stryker achieved their fifth consecutive quarterly EPS beat in Q2 2026. — Consistent earnings beats signal operational excellence and management reliability, supporting a bullish baseline for both names.
+0.30Which stocks this story touches
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Zacks Investment Research
42m ago
